SI2201002T1 - Antagonisti 5-ht7 receptorja - Google Patents

Antagonisti 5-ht7 receptorja

Info

Publication number
SI2201002T1
SI2201002T1 SI200830580T SI200830580T SI2201002T1 SI 2201002 T1 SI2201002 T1 SI 2201002T1 SI 200830580 T SI200830580 T SI 200830580T SI 200830580 T SI200830580 T SI 200830580T SI 2201002 T1 SI2201002 T1 SI 2201002T1
Authority
SI
Slovenia
Prior art keywords
receptor antagonists
migraine
formula
treatment
present
Prior art date
Application number
SI200830580T
Other languages
English (en)
Inventor
Valentina O Badescu
Sandra Ann Filla
Peter Thaddeus Gallagher
Maria Ann Whatton
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SI2201002T1 publication Critical patent/SI2201002T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200830580T 2007-10-12 2008-09-30 Antagonisti 5-ht7 receptorja SI2201002T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97946407P 2007-10-12 2007-10-12
EP08836911A EP2201002B1 (en) 2007-10-12 2008-09-30 5-ht7 receptor antagonists
PCT/US2008/078294 WO2009048765A1 (en) 2007-10-12 2008-09-30 5-ht7 receptor antagonists

Publications (1)

Publication Number Publication Date
SI2201002T1 true SI2201002T1 (sl) 2012-04-30

Family

ID=40134870

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830580T SI2201002T1 (sl) 2007-10-12 2008-09-30 Antagonisti 5-ht7 receptorja

Country Status (19)

Country Link
US (1) US7910588B2 (sl)
EP (1) EP2201002B1 (sl)
JP (1) JP5291716B2 (sl)
KR (1) KR101161070B1 (sl)
CN (1) CN101821257B (sl)
AT (1) ATE548365T1 (sl)
AU (1) AU2008311154B2 (sl)
BR (1) BRPI0818450A2 (sl)
CA (1) CA2699674C (sl)
CY (1) CY1112709T1 (sl)
DK (1) DK2201002T3 (sl)
EA (1) EA016787B1 (sl)
ES (1) ES2380756T3 (sl)
HR (1) HRP20120257T1 (sl)
MX (1) MX2010003986A (sl)
PL (1) PL2201002T3 (sl)
PT (1) PT2201002E (sl)
SI (1) SI2201002T1 (sl)
WO (1) WO2009048765A1 (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI396857B (zh) * 2009-12-30 2013-05-21 Etron Technology Inc 晶片測試電路
CA2849385A1 (en) 2011-10-11 2013-04-18 Ucb Pharma, S.A. 2-oxo-piperidinyl derivatives
WO2014164756A1 (en) 2013-03-11 2014-10-09 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
TW201601632A (zh) * 2013-11-20 2016-01-16 杜邦股份有限公司 1-芳基-3-烷基吡唑殺蟲劑
US10544117B2 (en) 2014-09-10 2020-01-28 Temple University—Of the Commonwealth System of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
CN110177776A (zh) 2016-11-15 2019-08-27 英联邦高等教育系统坦普尔大学 5-羟色胺受体7的新型调节剂及其使用方法
MA49017A (fr) 2017-03-21 2020-02-05 Univ Temple Modulateurs du récepteur 7 de la 5-hydroxytryptamine et utilisation de ces derniers en tant qu'agents thérapeutiques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) * 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US20030008880A1 (en) 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
JP2006516604A (ja) * 2003-01-31 2006-07-06 ファイザー・プロダクツ・インク 5ht7アンタゴニストおよび逆アゴニスト
US7211783B2 (en) 2004-01-09 2007-05-01 Tamperproof Container Licensing Corp. Tamper-proof container
EP1753429A1 (en) 2004-05-28 2007-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
TW200914020A (en) * 2007-08-28 2009-04-01 Lilly Co Eli Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

Also Published As

Publication number Publication date
AU2008311154B2 (en) 2013-09-26
CN101821257B (zh) 2013-05-22
CY1112709T1 (el) 2016-02-10
KR101161070B1 (ko) 2012-07-13
JP5291716B2 (ja) 2013-09-18
HRP20120257T1 (hr) 2012-04-30
PL2201002T3 (pl) 2012-07-31
ES2380756T3 (es) 2012-05-18
BRPI0818450A2 (pt) 2015-05-12
CA2699674A1 (en) 2009-04-16
KR20100054853A (ko) 2010-05-25
PT2201002E (pt) 2012-04-27
CN101821257A (zh) 2010-09-01
US7910588B2 (en) 2011-03-22
AU2008311154A1 (en) 2009-04-16
WO2009048765A1 (en) 2009-04-16
JP2011500575A (ja) 2011-01-06
CA2699674C (en) 2013-07-16
US20100197700A1 (en) 2010-08-05
DK2201002T3 (da) 2012-04-10
EP2201002A1 (en) 2010-06-30
EP2201002B1 (en) 2012-03-07
EA201070462A1 (ru) 2010-10-29
EA016787B1 (ru) 2012-07-30
MX2010003986A (es) 2010-04-27
ATE548365T1 (de) 2012-03-15

Similar Documents

Publication Publication Date Title
MY165113A (en) Piperidinone carboxamide azaindane cgrp receptor antagonists
JO2355B1 (en) Hereditary calcitonin polypeptide receptor antagonists
BRPI0514736A (pt) inibidores do receptor sigma
EP1608627A4 (en) BICYCLIC ANILID SPIROHYDANTOINS AS CGRP RECEPTOR ANTAGONISTS
EP1861399A4 (en) CGRP RECEPTOR ANTAGONISTS
TNSN08283A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
UA105911C2 (uk) Сульфонамідні похідні
TW200608960A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
MX338489B (es) Derivados de hidantoina utiles como inhibidores de kv3.
EP1606264A4 (en) ANTAGONISTS OF MONOCYCLIC SPIROHYDANTOIN ANILIDE CGRP RECEPTORS
EP1606286A4 (en) BENZODIAZEPINE SPIROHYDANTOINES AS CGRP RECEPTOR ANTAGONISTS
IL182317A0 (en) Cgrp receptor antagonists
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
CY1112709T1 (el) Ανταγωνιστες υποδοχεα 5-ητ7
EP1605936A4 (en) ARYL SPIROHYDANTINE CGRP RECEPTOR ANTAGONISTS
NZ590650A (en) Buprenorphine analogs
MX2009004745A (es) Derivados de 1,2,3-triazol como inhibidores del receptor sigma.
TW200734323A (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
MY147649A (en) Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders
EP1856100A4 (en) CGRP RECEPTOR ANTAGONISTS
DE602005027870D1 (de) Cgrp-rezeptorantagonisten
EA201101207A1 (ru) Применение антагонистов рецептора nk
MX2012007005A (es) Tiazoles biciclicos como moduladores alostericos de recptores de glutamato metabotropico subtipo 5.
EA200802104A1 (ru) Применение композиций, содержащих антагонисты каппа-опиоидных рецепторов, для лечения диссоциативных расстройств
MX2012007006A (es) Tiazoles biciclicos como moduladores alostericos de receptores mglur5.